Citation only
via Europe PMC
Changes in gray matter volume associated with gait speed and muscle mass in older adults with mild cognitive impairment.
Chuang TC, Liang CK, Chou MY, Chan YH, Wang HP, Wang YC, Hsu YH, Lin YT.
Journal of Alzheimer's disease : JAD · 2026
Abstract
BackgroundMild cognitive impairment (MCI) is an early stage of cognitive decline between normal aging and dementia. Gait speed, a key marker of physical function, has been associated with both cognitive decline and brain atrophy. Sarcopenia, characterized by age-related loss of muscle mass and function, has also been linked to structural brain changes.ObjectiveTo investigate the associations between sarcopenia, its individual components and regional gray matter volume (GMV) in older adults with MCI.MethodsThis cross-sectional study included 234 older adults with MCI. Sarcopenia, gait speed, handgrip strength, and appendicular skeletal muscle mass index (ASMI) were assessed according to the 2019 Asian Working Group for Sarcopenia criteria. Brain T1-weighted magnetic resonance imaging was analyzed using voxel-based morphometry. Voxel-wise group comparisons were performed to identify GMV differences after adjustment age, sex, comorbidity, depressive symptoms, nutritional status, and total intracranial volume.ResultsSlower gait speed was significantly associated with lower GMV in the bilateral putamen and left superior frontal cortex. Lower ASMI was associated with higher GMV in the left inferior temporal cortex. No significant GMV differences were found by sarcopenia status or handgrip strength.ConclusionsSlower gait speed is associated with reduced GMV in motor-related brain regions, indicating early brain structural changes in older adults with MCI. Although lower ASMI was associated with higher GMV, this finding should be interpreted cautiously. These findings highlight the complex interactions between physical function and brain structure, emphasizing gait speed as a potential indicator of brain health in older adults with MCI.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1177/13872877261500490
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
TC, C., CK, L., MY, C., YH, C., HP, W., YC, W., YH, H., & YT., L. (2026). Changes in gray matter volume associated with gait speed and muscle mass in older adults with mild cognitive impairment. <em>Journal of Alzheimer's disease : JAD</em>. https://doi.org/10.1177/13872877261500490
Vancouver
TC C, CK L, MY C, YH C, HP W, YC W, et al. Changes in gray matter volume associated with gait speed and muscle mass in older adults with mild cognitive impairment. Journal of Alzheimer's disease : JAD. 2026. doi:10.1177/13872877261500490.
BibTeX
@article{chuang2026Change,
title = {Changes in gray matter volume associated with gait speed and muscle mass in older adults with mild cognitive impairment.},
author = {Chuang TC and Liang CK and Chou MY and Chan YH and Wang HP and Wang YC and Hsu YH and Lin YT.},
journal = {Journal of Alzheimer's disease : JAD},
year = {2026},
doi = {10.1177/13872877261500490},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in aging neuroscience 2026
Citation only
Gut microbial characteristics and kynurenine-related metabolism across sarcopenia groups: associations with neuromuscular and physical function.
BMC Geriatrics 2015
Open access · CC-BY
Combined association of chronic disease and low skeletal muscle mass with physical performance in older adults in the Sarcopenia and Translational Aging Research in Taiwan (START) study
The Journals of Gerontology Series A 2019
Citation only
Systemic and Metabolic Signature of Sarcopenia in Community-Dwelling Older Adults
Experimental Gerontology 2025
Open access · CC-BY
Beyond quantity: Muscle quality as the cornerstone for sarcopenia diagnosis and healthy aging
Gaziosmanpasa Research and Education Hospital 2026
Open access · US-GOV
Effects of Aquatic Exercise Program on Muscle Strength, Muscle Mass, Physical Performance and Quality of Life in Older Adults With Sarcopenia: A Randomized Controlled Trial
Medicina (Kaunas, Lithuania) 2026
Citation only